Treatment of atypical pneumonia with azithromycin: Comparison of a 5-Day and a 3-Day course

Journal of Chemotherapy

Volumn 10, Issue 1, 1998, Pages 64-68

  Socan, M ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Azithromycin; Pneumonia atypica; Pneumonia in adults

Indexed keywords

AZITHROMYCIN;

ADENOVIRUS; ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CHLAMYDOPHILA PNEUMONIAE; CLINICAL TRIAL; COMPLEMENT FIXATION TEST; COXIELLA BURNETII; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIAE; ORAL DRUG ADMINISTRATION; PNEUMONIA; Q FEVER; SEROLOGY; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 0031915089     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1998.10.1.64     Document Type: Article

References (23)

1. Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med 1995; 333: 1618-1624.
2. Donowitz GR, Mandell GL. Acute pneumonia. In: Mandell GL, Bennett JE, Raphael D. eds, Principles and practice in infectious diseases. 4th ed. Vol. 1. New York: Churchill Livingstone, 1995: 619-637.
3. Marrie TJ, Haldane EV, Noble MA, Faulkner RS, Martin RS, Lee SHS. Causes of atypical pneumonia: results of a 1-year prospective study. Can Med Assoc J 1981; 125: 1118-1123.
4. Schlick W. The problems of treating atypical pneumonia. J Antimicrob Chemother 1993; 31: Suppl C: 111-120.
5. Wise R. The pharmacokinetics of azithromycin. Rev Contemp Pharmacother 1994; 5: 329-340.
6. Baldwin DR, Wise R, Andrews JM, Ashby JP, Honeybourne D. Azithromycin concentrations at the sites of pulmonary infections. Eur Respir J 1990; 3: 886-890.
7. Morris DI, De Souza A, Jones JA. Morgan WE. High and prolonged pulmonary tissue concentrations of azithromycin following a single oral dose. Eur J Clin Microbiol Infect Dis 1991; 10: 859-861.
8. Foulds G, Shepard RM, Johnson RB. The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 1990; 25: Suppl A: 73-82.
9. Foulds G, Johnson RB. Selection of dose regimens of azithromycin. J Antimicrob Chemother 1990; 25: Suppl A: 39-50.
10. Welsh LE, Gaydos CA, Quinn TC. In vitro evaluation of activities of azithromycin, erythromycin and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae. Antimicrob Agents Chemother 1992; 36: 291-294.
11. Renaudin H, Bebear C. Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum. Eur J Clin Microbiol Infect Dis 1990; 9: 838-841.
12. Edelstein PH. Antimicrobial chemotherapy for legionnaires′ disease: a review. Clin Infect Dis 1995; 21: Suppl C: S265-276.
13. Fitzgeorge RB, Featherstone ASR, Baskerville A. Efficacy of azithromycin in the treatment of guinea pigs infected with Legionella pneumophila by aerosol. J Antimicrob Chemother 1990; 25: Suppl A: 101-108.
14. Hoepelman AIM, Sips AP, van Helmond JLM et al. A single-blind comparison of three-day azithromycin and ten-day co-amoxiclav treatment of acute lower respiratory tract infections. J Antimicrob Chemother 1993; 25: Suppl E: 147-152.
15. Bradbury F. Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infections. J Antimicrob Chemother 1993; 25: Suppl E: 153-162.
16. Kinasewitz G, Wood RG. Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia. Eur J Clin Microbiol Infect Dis 1991; 10: 872-876.
17. Myburgh J, Nagel GJ, Petschel E. The efficacy and tolerance of a three-day course of azithromycin in the treatment of community-acquired pneumonia. J Antimicrob Chemother 1993; 25: Suppl E: 163-169.
18. Schonwald S, Gunjaca M, Kolacny-Babic L, Car V, Gošev M. Comparison of azithromycin and erythromycin in the treatment of atypical pneumonia. J Antimicrob Chemother 1990; 25: Suppl A: 101-108.
19. Schonwald S, Škerk V, Petricevic I, Car V, Majerus-Mi_ic LJ, Gunjaca M. Comparison of three-day and five-day azithromycin in the treatment of atypical pneumonia. Eur J Clin Microbiol Infect Dis 1991; 10: 877-880.
20. Kuzman I, Soldo I, Schonwald S, Culig J. Azithromycin for treatment of community-acquired pneumonia caused by Legionella pneumophila: a retrospective study. Scand J Infect Dis 1995; 27: 503-505.
21. Raoult D, Torres H, Drancourt M. Shell-vial assay: evaluation of new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii. Antimicrob Agents Chemother 1991; 35: 2070-2077.
22. Marrie TJ. Coxiella burnetii (Q fever) pneumonia. Clin Infect Dis 1995; 21: Suppl 3: S253-64.
23. Perez-del-Molino A, Aguado JM, Riancho JA, Sampedro I, Matorras P, Gonzales-Macias J. Erythromycin and the treatment of Coxiella burnetii pneumonia. J Antimicrob Chemother 1991; 28: 455-459.